Q3 2023 · 13F-HR
Sarissa Capital Management LPholdings as filed
Filed 2023-11-14 · accession 0000899140-23-001108
$742.4M
Reported value
11
Positions
2023-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| G01767105 | ALKS | ALKERMES PLC | $197.3M | 26.6% | 7,042,200 | Common | SOLE |
| 09062X103 | BIIB | BIOGEN INC | $165.3M | 22.3% | 643,000 | Common | SOLE |
| 46333X108 | IRWD | IRONWOOD PHARMACEUTICALS INC | $157.8M | 21.3% | 16,390,000 | Common | SOLE |
| 45781M101 | INVA | INNOVIVA INC | $94.5M | 12.7% | 7,277,000 | Common | SOLE |
| 375558103 | GILD | GILEAD SCIENCES INC | $69.0M | 9.29% | 920,400 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $41.2M | 5.55% | 366,000 | Common | SOLE |
| 023111206 | — | AMARIN CORP PLC | $9.6M | 1.29% | 10,442,453 | Common | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $5.5M | 0.74% | 775,000 | Common | SOLE |
| 929033108 | — | VOR BIOPHARMA INC | $1.3M | 0.18% | 618,000 | Common | SOLE |
| 59045L106 | — | MERSANA THERAPEUTICS INC | $698,500 | 0.09% | 550,000 | Common | SOLE |
| 75915K309 | RGLS | REGULUS THERAPEUTICS INC | $253,701 | 0.03% | 185,183 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.